Psychedelics Research Links August 2021
This is all the other psychedelic research that came out in August 2021.
Research
Research Briefing: Making psychedelics at scale
In the Research Briefing of July 23rd: 1) LSD increases empathy via oxytocin independent of serotonin receptor activity 2) Low dose LSD engenders therapeutic processes by inducing suggestibility alongside psychosis-like phenomena and mystical experiences 3) Novel gene repression method improves the yield of psilocybin biosynthesis by over 300%
Research Briefing: Will psychedelics change your worldview?
In the Research Briefing of July 8th 1) Sustained improvements in well-being after psychedelic experiences 2) Psychedelic shift metaphysical beliefs away from materialistic 3) Treating anorexia with psychedelics looks promising
Clinical Trials
Psychedelics are set to be approved as medicines after they go through clinical trials | Learn which drugs & companies are taking the lead
Psychedelics Research Links July 2021
This is all the other psychedelic research that came out in July 2021.
Psychedelics Research Recap June 2021
Psychedelic research in June continued the path towards making psychedelics available as medicines. From those who use mental health services to the general public, everyone has to get on board before we can get there.
Research Briefing: What do patients think of psychedelics as medicines?
In the Research Briefing of June 24th 1) Are patients ready for psychedelics as medicines? A survey study provides answers 2) Microdosing for creativity still not catching a break 3) Ketamine helps those with chronic migraines find temporary relief
Research Briefing: Predicting who will quit drugs based on their trip report
In the Research Briefing of June 10th 1) Using machine learning to predict who will quit alcohol and opioids after a psychedelic trip 2) Positive outcomes after an ayahuasca retreat, with improvements at the 6-month follow-up 3) The fMRI data for psychedelic neuroimaging is less organized than one hopes for
Research Briefing: Breaking free from a negativity bias with psychedelics
In the Research Briefing of June 3rd 1) Reducing negativity bias in depressed patients with psychedelics 2) Psychedelic trials focus mainly on MDMA and psilocybin at this time 3) Positive long-term outcomes after bad trips and a more complete picture of such experiences
Psychedelics Research Links June 2021
This is all the other psychedelic research that came out in June 2021.